Research and Development (R&D)

Key TakeawaysMainz Biomed begins the eAArly DETECT 2 feasibility study to evaluate its advanced colorectal cancer (CRC) diagnostic test. The study will involve...

Key TakeawaysSTRIDES Phase 2 trial for azelaprag in obesity treatment discontinued due to observed liver transaminitis. Company to assess data and announce updated...

Key TakeawaysBemnifosbuvir and ruzasvir regimen achieved 98% sustained virologic response (SVR12) in Phase 2 study. The treatment was well-tolerated with no serious adverse...

Key TakeawaysZetaMAST™ shows fourfold tumor volume reduction in liver metastases. Survival rates improved by nearly 4x over standard treatment. Zetagen plans to advance...

Key TakeawaysCytomos raises £5 million to scale its AuraCyt™ cell analysis platform and commercialize Celledonia™. AuraCyt™ enables biopharma companies to develop therapies faster...

Key TakeawaysWRAPSODY achieves 82% target lesion primary patency at six months, exceeding performance goals. The WAVE trial highlights significant improvements in vascular access...

Key TakeawaysThe 2024 San Antonio Breast Cancer Symposium (SABCS) will host nearly 11,000 participants. Researchers, healthcare professionals, and advocates will present the latest...

Key TakeawaysDZP achieved a 14.6% higher BICLA response rate at 48 weeks compared to SOC alone. Participants on DZP experienced a 50% reduction...

Key TakeawaysThe 35mg dosage regimen was well-tolerated, with minimal severe side effects. Patients exhibited a 30% increase in overall survival rates. The targeted...

Key TakeawaysThe EU's transferable exclusivity voucher (TEV) provides a lucrative incentive for developing new antimicrobials. Minimal investment in TEV schemes can prevent exorbitant...

Key TakeawaysArcturus Therapeutics received FDA clearance to begin clinical trials for a nano-based influenza vaccine targeting H5N1. The vaccine, ARCT-2304, utilizes sa-mRNA technology...

Key TakeawaysImplementing free and accessible treatment programs can drastically increase patient uptake rates. Targeted interventions in high-risk communities are crucial for reducing disease...

Key TakeawaysPersonalized chemotherapy decisions should be guided by comprehensive biomarker evaluations. Premenopausal women under 50 with certain biomarker profiles may face increased risks...

Key TakeawaysRepotrectinib shows strong efficacy in treating advanced ROS1-positive NSCLC and NTRK-positive solid tumors. Positive CHMP recommendation paves the way for EU approval...

Key TakeawaysResearchers can now submit proposals online, reducing administrative burdens. The collaboration with NRPB-IRB ensures more consistent ethical standards across institutions. Expanded committee...